Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Global Market for Contract Research Organization (CRO) Services
... of the clinical trial process, including a detailed description of all the phases and functional services CROs associated with clinical trials; and it details the major therapeutic areas covered by CROs and their broad service ... Read More
-
Medical Cannabis Market: Global Market Size, Forecast, Insights, and Competitive Landscape
... holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the medical cannabis market by segmenting the market based on species, molecule, end ... Read More
-
Esophageal Cancer: Competitive Landscape
... the 16 countries covered in GlobalData’s epidemiology forecast. Chemotherapy forms the backbone of therapy in patients with advanced or metastatic EC. There are 22 innovator drugs marketed for EC across geographies. The EC pipeline has ... Read More
-
Limb-Girdle Muscular Dystrophy (LGMD): Competitive Landscape
... are anticipated in the 16 countries covered in GlobalData’s epidemiology forecast. No disease-modifying treatment has proven to alter LGMD progression so far, and thus symptom management remains the mainstay of care. The LGMD pipeline holds ... Read More
-
Regulatory Affairs Outsourcing
... by 2030, growing at a CAGR of 8.5% over the analysis period 2023-2030. Regulatory Submissions End-Use, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$1.7 Billion ... Read More
-
Clinical Trial Imaging
... at a CAGR of 5.5% over the analysis period 2023-2030. Project & Data Management Service, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$472.8 Million by ... Read More
-
Bronchiectasis - Market Insight, Epidemiology And Market Forecast - 2034
... the forecast period (2024–2034). This growth is primarily driven by rising diagnosed prevalent cases and the introduction of emerging therapies. According to DelveInsight's analysis, it is projected that approximately 41% of the Total Diagnosed Prevalent ... Read More
-
Clinical Trial Supplies
... at a CAGR of 4.7% over the analysis period 2023-2030. Phase I Clinical Trial Supplies, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$532.1 Million by ... Read More
-
Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology And Market Forecast - 2034
... a full or partial extra copy of chromosome 21. This additional genetic material alters development, leading to the physical and intellectual characteristics associated with Down’s syndrome. The market size of Down’s syndrome in 2023 was ... Read More
-
Clinical Data Analytics
... by 2030, growing at a CAGR of 30.5% over the analysis period 2023-2030. Quality Car Application e, one of the segments analyzed in the report, is expected to record a 29.8% CAGR and reach US$58.8 ... Read More
-
Alzheimer’s Disease Drugs
... by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Donepezil, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$5.2 Billion by the ... Read More
-
Healthcare Contract Research Organization (CRO)
... is expected to reach US$83.6 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Clinical Type, one of the segments analyzed in the report, is expected to record a 5.4% ... Read More
-
Myotonic Dystrophy Market Insight, Epidemiology And Market Forecast - 2034
... United States accounted for 45% of the cases, while Japan and Germany represented 9% and 18% of the cases, respectively. DelveInsight’s epidemiology model projects that Parkinson’s disease cases in the US included nearly 695 thousand ... Read More
-
Global Clinical Research Digitization Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. The Global Info Research report includes an overview of the development of the ... Read More
-
Gonorrhea (GN): Competitive Landscape
... the 16 countries covered in GlobalData’s epidemiology forecast. Currently, the GN market contains many innovative therapies developed by big pharma giants. R&D efforts for GN are limited. Currently, 33 molecules are in the pipeline, with ... Read More
-
Pre-eclampsia - Early-stage Therapy - Pipeline Insight 2024
... of gestation and is characterized by high blood pressure, proteinuria, and sometimes organ damage such as kidney impairment, liver dysfunction, or neurological symptoms. Moreover, if left untreated or if it becomes severe, pre-eclampsia can result ... Read More
-
Multiple System Atrophy (MSA): Competitive Landscape
... are anticipated in the 16 countries covered in GlobalData’s epidemiology forecast. Currently, there is only one approved therapy available on the market for MSA. The MSA pipeline holds 41 molecules, with no assets in the ... Read More
-
Vaccine Contract Manufacturing Market: Global Market Size, Forecast, Insights, and Competitive Landscape
... contract manufacturing market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global vaccine contract manufacturing market by segmenting ... Read More
-
Dry Age Macular Degeneration (Dry Amd) - Early-stage Therapy - Pipeline Insight 2024
... population, leading to the deterioration of the macula, the central region of the retina. This condition results in a gradual loss of central vision, making daily activities such as reading and driving increasingly challenging. AMD ... Read More
-
Clinical Trials Market Analysis and Forecast to 2033: By Phase (Phase I, Phase Ii, Phase Iii, Phase Iv, Preclinical), Design (Interventional Trials, Observational Trials, Expanded Access Trials), Indication (Oncology, Cardiology, Neurology, Infectious Diseases, Gastroenterology, Immunology, Respiratory, Endocrinology, Dermatology, Ophthalmology), Study Type (Randomized Controlled Trials, Non-Randomized Controlled Trials, Adaptive Trials, Single-Arm Trials), Service Type (Clinical Trial Management, Patient Recruitment, Laboratory Services, Data Management), End User (Pharmaceutical Companies, Contract Research Organizations, Academic Institutions, Medical Device Manufacturers, Public Health Organizations), and Region
... Respiratory, Endocrinology, Dermatology, Ophthalmology), Study Type (Randomized Controlled Trials, Non-Randomized Controlled Trials, Adaptive Trials, Single-Arm Trials), Service Type (Clinical Trial Management, Patient Recruitment, Laboratory Services, Data Management), End User (Pharmaceutical Companies, Contract Research Organizations, Academic ... Read More
-
Glycogen Storage Disorders (GSD): Competitive Landscape
... are anticipated in the 16 countries covered in GlobalData’s epidemiology forecast. Most of the marketed drugs for GSD are enzyme replacement therapies. The Phase III pipeline consists of two drugs, with seven drugs in Phase ... Read More
-
Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
... Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Transmucosal Drug Delivery pipeline products with comparative analysis of the products at various stages of development and information about ... Read More
-
Clinical Trial Biorepository & Archiving Solutions Market Size, Share, Trends, Industry Analysis Report: By Product (Preclinical Products and Clinical Products), By Service, By Phase, and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2024–2032
... Middle East & Africa) – Market Forecast, 2024–2032 The global clinical trial biorepository & archiving solutions market size is expected to reach USD 8.09 billion by 2032, according to a new study by Polaris Market ... Read More
-
C-X-C Chemokine Receptor 4 (CXCR4) Antagonists Global Market Report 2024 Including: 1) By Type: BL-8040; GMI-1359; Plerixafor (AMD3100); Balixafortide (POL6326); USL311; Burixafor (GPC-100) 2) By Route Of Administration: Oral; Injectable 3) By Product Pipeline: Approved; Clinical Trials; Pre-Clinical 4) By Application: Cancer; Human Immunodeficiency Virus (HIV); Chronic Inflammatory Disease; Stem Cell Mobilization; Immune And Autoimmune Diseases 5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies Covering: Pfizer Inc.; F-Hoffmann La Roche Ltd.; Sanofi; Bristol-Myers Squibb Company; AstraZeneca plc
... Pre-Clinical4) By Application: Cancer; Human Immunodeficiency Virus (HIV); Chronic Inflammatory Disease; Stem Cell Mobilization; Immune And Autoimmune Diseases5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online PharmaciesCovering: Pfizer Inc.; F-Hoffmann La Roche Ltd.; Sanofi; Bristol-Myers ... Read More
-
Menopausal Hot Flashes Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... pandemic has posed severe challenges to healthcare systems and has drastically cut down in- and outpatient services in hospitals and clinics. The lockdown measures and restrictions imposed by the government have impacted the lives of ... Read More
Research Assistance
